Literature DB >> 16951736

Fluoxetine-induced alterations in human platelet serotonin transporter expression: serotonin transporter polymorphism effects.

Karley Y Little1, Lian Zhang, Edwin Cook.   

Abstract

OBJECTIVE: Long-term antidepressant drug exposure may regulate its target molecule - the serotonin transporter (SERT). This effect could be related to an individual's genotype for an SERT promoter polymorphism (human serotonin transporter coding [5-HTTLPR]). We aimed to determine the effects of fluoxetine exposure on human platelet SERT levels.
METHOD: We harvested platelet samples from 21 healthy control subjects. The platelets were maintained alive ex vivo for 24 hours while being treated with 0.1 muM fluoxetine or vehicle. The effects on SERT immunoreactivity (IR) were then compared. Each individual's SERT promoter genotype was also determined to evaluate whether fluoxetine effects on SERT were related to genotype.
RESULTS: Fluoxetine exposure replicably altered SERT IR within individuals. Both the magnitude and the direction of effect were related to a person's SERT genotype. People who were homozygous for the short gene (SS) displayed decreased SERT IR, whereas those who were homozygous for the long gene (LL) demonstrated increased SERT IR. A mechanistic experiment suggested that some individuals with the LL genotype might experience increased conversion of complexed SERT to primary SERT during treatment.
CONCLUSIONS: These preliminary results suggest that antidepressant effects after longer-term use may include changes in SERT expression levels and that the type and degree of effect may be related to the 5-HTTLPR polymorphism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16951736      PMCID: PMC1557681     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  38 in total

1.  Reactivity of serotonin in whole blood.

Authors:  Erik J Mulder; George M Anderson; Ido P Kema; Ruud B Minderaa
Journal:  Biol Psychiatry       Date:  2002-02-01       Impact factor: 13.382

2.  Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression.

Authors:  B G Pollock; R E Ferrell; B H Mulsant; S Mazumdar; M Miller; R A Sweet; S Davis; M A Kirshner; P R Houck; J A Stack; C F Reynolds; D J Kupfer
Journal:  Neuropsychopharmacology       Date:  2000-11       Impact factor: 7.853

3.  Is there a delay in the antidepressant effect? A meta-analysis.

Authors:  Michael A Posternak; Mark Zimmerman
Journal:  J Clin Psychiatry       Date:  2005-02       Impact factor: 4.384

4.  Cocaine induction of dopamine transporter trafficking to the plasma membrane.

Authors:  Karley Y Little; Lawrence W Elmer; Huailing Zhong; Joshua O Scheys; Lian Zhang
Journal:  Mol Pharmacol       Date:  2002-02       Impact factor: 4.436

5.  Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients.

Authors:  Keizo Yoshida; Kenichi Ito; Kazuhiro Sato; Hitoshi Takahashi; Mitsuhiro Kamata; Hisashi Higuchi; Tetsuo Shimizu; Kunihiko Itoh; Kazuyuki Inoue; Takehiko Tezuka; Toshio Suzuki; Tadashi Ohkubo; Kazunobu Sugawara; Koichi Otani
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2002-02       Impact factor: 5.067

6.  Serotonin transporter gene polymorphism and antidepressant response.

Authors:  D K Kim; S W Lim; S Lee; S E Sohn; S Kim; C G Hahn; B J Carroll
Journal:  Neuroreport       Date:  2000-01-17       Impact factor: 1.837

7.  Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level.

Authors:  S Benmansour; M Cecchi; D A Morilak; G A Gerhardt; M A Javors; G G Gould; A Frazer
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

8.  No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism.

Authors:  M Willeit; J Stastny; W Pirker; N Praschak-Rieder; A Neumeister; S Asenbaum; J Tauscher; K Fuchs; W Sieghart; K Hornik; H N Aschauer; T Brücke; S Kasper
Journal:  Biol Psychiatry       Date:  2001-07-01       Impact factor: 13.382

9.  A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide.

Authors:  J J Mann; Y Y Huang; M D Underwood; S A Kassir; S Oppenheim; T M Kelly; A J Dwork; V Arango
Journal:  Arch Gen Psychiatry       Date:  2000-08

10.  The role of serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder: preliminary findings.

Authors:  E Mundo; M Walker; T Cate; F Macciardi; J L Kennedy
Journal:  Arch Gen Psychiatry       Date:  2001-06
View more
  3 in total

1.  Boron-Doped Diamond Microelectrodes Reveal Reduced Serotonin Uptake Rates in Lymphocytes from Adult Rhesus Monkeys Carrying the Short Allele of the 5-HTTLPR.

Authors:  Yogesh S Singh; Lauren E Sawarynski; Heather M Michael; Robert E Ferrell; Michael A Murphey-Corb; Greg M Swain; Bhavik A Patel; Anne M Andrews
Journal:  ACS Chem Neurosci       Date:  2010-01-20       Impact factor: 4.418

2.  Development and validation of the high-quality 'rapid method for swab' to genotype the HTTLPR serotonin transporter (SLC6A4) promoter polymorphism.

Authors:  Bryan Maloney; Balmiki Ray; Elizabeth P Hayden; John I Nurnberger; Debomoy K Lahiri
Journal:  Psychiatr Genet       Date:  2009-04       Impact factor: 2.458

3.  Maternal depression and anxiety are associated with altered gene expression in the human placenta without modification by antidepressant use: implications for fetal programming.

Authors:  Kathryn L Ponder; Amy Salisbury; Bethany McGonnigal; Alyse Laliberte; Barry Lester; James F Padbury
Journal:  Dev Psychobiol       Date:  2011-05-05       Impact factor: 3.038

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.